May 9, 2023 — AstraZeneca’s Farxiga (dapagliflozin) has been approved
FDA Approves Mydcombi
FDA Approves Mydcombi (tropicamide and phenylephrine hydrochloride) Ophthalmic Spray for
FDA Approves Rezzayo
FDA Approves Rezzayo (rezafungin for injection) for the Treatment of
FDA Approves Zavzpret
FDA Approves Zavzpret (zavegepant) Nasal Spray for the Acute Treatment
Centene Agrees to $215 Million Settlement With California for Alleged Medicaid Overbilling
Centene Corp. has agreed to pay more than $215 million
Stopping the Churn: Why Some States Want to Guarantee Medicaid Coverage From Birth to Age 6
Before the covid-19 public health emergency began in 2020, millions
Did the US Jump the Gun With the New Omicron-Targeted Vaccines?
Last month, the FDA authorized omicron-specific vaccines, accompanied by breathless
Readers and Tweeters Sound Alarm Over Nurse’s Homicide Trial
Letters to the Editor is a periodic feature. We welcome all comments and
Montana Is Sending Troubled Kids to Out-of-State Programs That Have Been Accused of Abuse
The high demand for treatment for children with behavioral and
Backlogs in California’s Medicaid Drug Program Ease, but Problems Persist
SACRAMENTO, Calif. — The contractor running California’s new Medicaid prescription drug